SYNTHESIS, HYDROLYSIS AND ANTI-EBV ACTIVITY OF A SERIES OF 3′-MODIFIEDcycloSal-BVDUMP PRONUCLEOTIDES
- 31 March 2001
- journal article
- Published by Taylor & Francis in Nucleosides, Nucleotides and Nucleic Acids
- Vol. 20 (4-7) , 307-314
- https://doi.org/10.1081/ncn-100002301
Abstract
A series of cycloSal-BVDUMP phosphate triesters has been prepared. The prototype compound was 3-methyl-cycloSal-BVDUMP 2. Furthermore, a series of 3'-O-acyl-modified derivatives having carboxylic acids with different lipophilicity or a L-configurated alpha-amino acid (phenylalanine) was prepared. The hydrolysis properties in phosphate buffer PBS as well as in PBS containing pig liver esterase (PLE) will be described. Finally, the biological activity against EBV has been determined.Keywords
This publication has 21 references indexed in Scilit:
- cycloSal-Pronucleotides of 2‘-Fluoro-ara- and 2‘-Fluoro-ribo-2‘,3‘- dideoxyadenosine as a Strategy to Bypass a Metabolic BlockadeJournal of Medicinal Chemistry, 1999
- cycloSal-Pronucleotides of 2‘,3‘-Dideoxyadenosine and 2‘,3‘-Dideoxy-2‘,3‘-didehydroadenosine: Synthesis and Antiviral Evaluation of a Highly Efficient Nucleotide Delivery SystemJournal of Medicinal Chemistry, 1999
- CycloSal-2′-ara (ribo)-fluoro-2′,3′-dideoxyadenosine Monophosphates—An Effort to Solve the Structure-Activity Relationship of 2′-Fluoro-ddaNucleosides and Nucleotides, 1999
- Nucleotide Delivery fromcycloSaligenyl-3′-azido-3′-deoxythymidine Monophosphates (cycloSal-AZTMP)European Journal of Organic Chemistry, 1998
- cycloSal-2‘,3‘-dideoxy-2‘,3‘-didehydrothymidine Monophosphate (cycloSal-d4TMP): Synthesis and Antiviral Evaluation of a New d4TMP Delivery SystemJournal of Medicinal Chemistry, 1998
- Pro-Nucleotides - Recent Advances in the Design of Efficient Tools for the Delivery of Biologically Active Nucleoside MonophosphatesSynlett, 1998
- ADA-Bypass by lipophilic cycloSal-ddAMP pro-nucleotides A second example of the efficiency of the cycloSal-ConceptBioorganic & Medicinal Chemistry Letters, 1997
- 2‐Nucleos‐5′‐O‐yl‐4H‐1,3,2‐benzodioxaphosphinin‐2‐oxide—ein neues Konzept für lipophile, potentielle Prodrugs biologisch' aktiver NucleosidmonophosphateAngewandte Chemie, 1996
- Metabolism and mechanism of antiretroviral action of purine and pyrimidine derivativesInternational Journal of Clinical Pharmacy, 1994
- Chemotherapeutic approaches to the treatment of the acquired immune deficiency syndrome (AIDS)Journal of Medicinal Chemistry, 1986